Synthetic Canines: A $200 Million Push for Engineered War Dogs

A startup called Warhound emerged from stealth mode this week with a $200 million funding round to develop genetically engineered dogs for the U.S. military and law enforcement. The venture is valued at $1.2 billion and is backed by prominent investors including Sequoia, 8VC, Corner Ventures, and In-Q-Tel. The latter is a venture firm supported by the CIA and other U.S. intelligence agencies. The company aims to solve a critical supply issue by creating canines that are better suited for dangerous and complex missions than traditional working dogs.

The core of the project is a collaboration between Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. Lamm met Luckey at a conference about a year ago, where they discussed the challenges facing the U.S. military’s working dog population. Lamm subsequently researched how these dogs are bred and discovered that many fail training due to inherited health issues. These problems include poor eyesight, hip dysplasia, muscle atrophy, and a high likelihood of cancer. Warhound intends to use gene editing to remove these negative traits and enhance characteristics such as speed, agility, and olfactory sensitivity for tasks like bomb detection.

The company notes that over 80% of the U.S. military’s working dogs are currently imported from Europe. Furthermore, less than half of those imported dogs are deemed fit for service. This reliance on foreign sources highlights a dwindling domestic supply. Warhound plans to change this dynamic by engineering dogs with specific traits suited to demanding missions. The team is studying top-performing breeds, such as the Belgian Malinois and German Shepherd, by keeping cell lines from them in a biobank. They will then edit the genes to create a new type of dog optimized for military work.

Anduril will play a significant role by providing the hardware and software needed to support these animals. This includes protection vests and goggles that assist both the dogs and their handlers with situational awareness. Lamm described the technology as a way to make the dogs safer and healthier beyond their genetics. For example, bulletproof vests could contain data sensors that send information back to handlers, giving them a better understanding of the environment. This approach places the technology on the dog rather than inside it, aiming to better protect the human handlers as well.

The first batch of these engineered dogs is expected to be cloned and incubated soon. Births are anticipated in early 2027, with the dogs ideally beginning service within two years. Viagen, another company owned by Colossal, will partner with Warhound to handle the cloning process. Lamm stated that Viagen’s technology has a high success rate, which is already being used in Colossal’s programs to protect endangered species. Colossal is known for its de-extinction efforts to bring back animals like the dodo and the mammoth, and it will support Warhound by licensing its gene editing technology.

Warhound has not yet determined the price it will charge for these animals. The company expects to sell them to first responders, the Department of Defense, various military service groups, and police forces. Lamm confirmed that Luckey is a partner in the venture but does not own equity in the company. Colossal, however, does hold equity and provides technological support. The company has briefed numerous government groups about the business, though specific details on the approval process remain limited.

Addressing concerns about civilian safety, Lamm noted that each dog will undergo standard military working dog training. They will be managed by the organization that purchases them. To ensure ethical treatment, Warhound is working under the guidance of the American Humane Society. The Society is helping to certify the training program for the new dogs. There is also a hope that these military dogs will enter the Society’s Military Working Dog Reunification Program upon retirement, which provides homes for retired canines.

The American Humane Society issued a statement applauding Warhound and Colossal for inviting them to participate in the project. The organization described itself as grounded in science and ethics and expressed its desire to work with the companies to ensure the animals are treated humanely. This partnership aims to address potential ethical questions surrounding the use of genetically modified animals in high-stakes environments.